| Literature DB >> 33815255 |
Yazhou Lin1,2, Qiang Gao2, Huiping Jin1, Nana Wang1, Dingkang Xu2, Fang Wang2, A Bao Guo1, Weidong Zang1, Zhihua Li1, Fuyou Guo2.
Abstract
Objectives: We identified the optimal approaches for treating the diverse tumor subtypes of petroclival meningioma (PM) by analyzing the clinical benefits of various surgical approaches adopted for each subtype.Entities:
Keywords: meningioma; petroclival; skull base; surgical approach; tumor subtypes
Year: 2021 PMID: 33815255 PMCID: PMC8018277 DOI: 10.3389/fneur.2021.627736
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Summary of general characteristics in patients with PM.
| Mean ± SD | 52.3 ± 9.9 | |
| Range | 26–74 | |
| Male | 21 (20.6) | |
| Female | 81 (79.4) | |
| Mean ± SD | 17.0 ± 27.6 | |
| Range | 0.3–156 | |
| CN II | 3 (2.9) | |
| CN III | 4 (3.9) | |
| CN IV | 5 (4.9) | |
| CN V | 18 (17.7) | |
| CN VI | 6 (5.9) | |
| CN VII | 7 (6.9) | |
| CN VIII | 10 (9.8) | |
| CN IX | 6 (5.9) | |
| CN X | 4 (3.9) | |
| CN XI | 4 (3.9) | |
| None | 35 (34.3) | |
| Headache or dizziness | 55 (53.9) | |
| Epilepsy | 1 (1) | |
| Dysarthria | 11 (10.8) | |
| Medical examination | 35 (34.3) | |
| Recurrence, | 8(7.8) | |
| Follow-up, | 97 (96) | |
| UC | 30 (29.4) | |
| CS | 25 (24.5) | |
| TE | 31 (30.4) | |
| PA | 16 (15.7) | |
| UC | 29.1 ± 6.47 | |
| CS | 35.8 ± 6.49 | |
| TE | 27.6 ± 11.32 | |
| PA | 26.3 ± 12.8 |
CS, cavernous sinus type; CN, Cranial nerve; PA, petrous apex type; PM, Petroclival meningioma; TE, tentorium type; UC, upper clivus type.
Figure 1Four subtypes of petroclival meningioma (A) Upper clivus type petroclival meningiomas (UC). (B) Cavernous sinus type petroclival meningiomas (CS). (C) Tentorium-type petroclival meningioma (TE). (D) Petrous apex type petroclival meningiomas (PA).
Figure 2The tumor equivalent diameter (TED) of various PM subtypes. The TED of the CS type was significantly different from those of the other three types of PM (*P < 0.05).
Degree of resection of four tumor types in patients with PM.
| Subtemporal | 1 | 5 | 3 | 1 | 0 |
| Retromastoid | 1 | 2 | 2 | 0 | 0 |
| Kawase | 7 | 7 | 1 | 0 | 0 |
| Subtemporal | 0 | 0 | 11 | 4 | 0 |
| Kawase | 0 | 0 | 7 | 3 | 0 |
| Retromastoid | 1 | 4 | 2 | 1 | 0 |
| Kawase | 12 | 8 | 2 | 1 | 0 |
| Retromastoid | 0 | 5 | 1 | 1 | 0 |
| Kawase | 5 | 3 | 1 | 0 | 0 |
CS, cavernous sinus type; CN, Cranial nerve; PA, petrous apex type; PM, Petroclival meningioma; TE, tentorium type; UC, upper clivus type.
Preoperative, postoperative and recent KPS of subtype.
| UC | Subtemporal | 10 (9.80) | 68 ± 9.80 (65) | 468.5 ± 186.51 | 74 ± 12.81 (70) | 67.8 ± 22.3 (80) | 22.1 ± 3.45 |
| Retromastoid | 5 (4.90) | 62 ± 22.27 (70) | 323.2 ± 127.80 | 74 ± 27.28 (90) | 68 ± 34.30 (80) | 23 ± 13.13 | |
| Kawase | 15 (14.71) | 68.6 ± 8.05 (70) | 482.2 ± 66.2 | 75 ± 8.84 (70) | 86 ± 24.44 (90) | 24.2 ± 9.52 | |
| CS | Subtemporal | 15 (14.71) | 71.3 ± 10.87 (70) | 350.87 ± 82.86 | 78 ± 10.46 (80) | 86.8 ± 24.13 (90) | 20 ± 3.25 |
| Kawase | 10 (9.80) | 69 ± 7 (70) | 376.5 ± 105.18 | 77.5 ± 4.33 (80) | 85 ± 15 (95) | 24.8.8 ± 15.8 | |
| TE | Retromastoid | 8 (7.84) | 70 ± 10 (70) | 414.5 ± 42.56 | 77.5 ± 6.14 (80) | 85 ± 11.18 (90) | 19.25.3 ± 3.86 |
| Kawase | 23 (22.55) | 62 ± 19.39 (70) | 385.52 ± 81.24 | 74.8 ± 19.5 (80) | 83.9 ± 27.30 (90) | 24.2 ± 13.36 | |
| PA | Retromastoid | 7 (6.86) | 72.85 ± 6.99 (70) | 412.43 ± 39.07 | 75.7 ± 9.03 (80) | 88.57 ± 11.2 (90) | 19.85 ± 0.83 |
| Kawase | 9 (8.82) | 70 ± 8.16 (70) | 443.33 ± 73.71 | 83.3 ± 9.42 (80) | 93.33 ± 9.42 (100) | 16.44 ± 1.89 | |
| Total | 102 | 68.72 ± 12.1 (70) | 369.63 ± 116.96 | 76.3 ± 15.2 (80) | 83.64 ± 24.78 (90) | 22.58 ± 9.86 |
CS, cavernous sinus type; KPS, Karnofsky performance scale; PA, petrous apex type; TE, tentorium type; UC, upper clivus type.
Figure 3Different surgical approaches and KPS score improvement for each tumor subtype. The Kawase approach significantly improved the KPS scores at follow-up compared with the other two approaches for the UC and PA type (*P < 0.05).
Recovery of UC type cranial nerve injury.
| CN II | – | – | 1 | – | – | – | – | – | – |
| CN II | – | – | – | – | – | – | – | – | – |
| CN IV | – | – | – | 2 | – | – | – | – | – |
| CN V | 1 | – | – | 2 | – | – | – | – | – |
| CN VI | – | – | – | – | – | – | – | – | – |
| CN VII | – | – | – | – | – | – | 2 | – | – |
| CN VIII | – | – | – | – | – | – | 2 | – | – |
| CN IX | – | – | – | 1 | – | – | 1 | – | – |
| CN X | 1 | 1 | – | – | – | – | 1 | – | – |
| CN XI | – | – | – | – | – | – | 1 | – | – |
| Ataxia | – | – | – | – | – | – | 1 | – | 1 |
| Dizziness | 3 | – | – | 3 | – | – | 2 | – | 2 |
CN, Cranial nerve; D, Deterioration; NO, new onset; UC, upper clivus type.
Recovery of CS type cranial nerve injury.
| CN II | – | – | 1 | 1 | – | – |
| CN III | 2 | – | – | – | – | 1 |
| CN IV | 1 | – | 1 | 1 | – | – |
| CN V | 2 | – | – | 1 | – | – |
| CN VI | 1 | 1 | – | 1 | 1 | 1 |
| CN VII | – | – | – | 1 | – | – |
| CN VIII | – | – | – | – | – | – |
| CN IX | – | – | – | – | – | – |
| CN X | – | – | – | – | – | – |
| CN XI | – | – | – | – | – | – |
| Ataxia | – | – | – | – | – | – |
| Dizziness | 3 | – | – | 5 | – | 2 |
CN, Cranial nerve; D, Deterioration; NO, new onset; CS, cavernous sinus type.
Recovery of TE type cranial nerve injury.
| CN II | – | – | – | – | – | – |
| CN III | 1 | – | – | – | – | – |
| CN IV | 1 | – | 1 | – | – | – |
| CN V | 1 | 1 | – | 3 | 1 | 2 |
| CN VI | – | – | 1 | – | – | 1 |
| CN VII | – | – | – | 1 | – | – |
| CN VIII | 1 | – | – | 3 | – | – |
| CN IX | – | – | – | 1 | – | – |
| CN X | 1 | – | – | 2 | – | – |
| CN XI | – | – | – | – | – | – |
| Ataxia | – | – | – | – | – | – |
| Dizziness | 3 | – | – | 4 | – | 2 |
CN, Cranial nerve; D, Deterioration; NO, new onset; TE, tentorium type.
Recovery of PA type cranial nerve injury.
| CN II | – | – | – | – | – | – |
| CN III | – | – | – | – | – | – |
| CN IV | – | – | – | – | – | – |
| CN V | 3 | – | – | 2 | – | – |
| CN VI | 1 | – | – | – | – | 1 |
| CN VII | 1 | – | 1 | – | – | – |
| CN VIII | 1 | – | – | 1 | – | 1 |
| CN IX | – | – | – | 1 | – | – |
| CN X | – | – | – | – | – | – |
| CN XI | 1 | – | – | – | – | – |
| Ataxia | 2 | – | – | 1 | – | – |
| Dizziness | 3 | – | – | 4 | – | – |
CN, Cranial nerve; D, Deterioration; NO, new onset; PA, petrous apex type.